机构:[1]Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.[2]Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China.[3]Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.[4]Department of Medical Oncology, The First Hosptial of Putian, Fujian Medical University Teaching Hospital, Putian, China.[5]Department of Radiation Oncology, Sichuan Cancer Hospital Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.四川省人民医院四川省肿瘤医院
Fujian Provincial Health Technology Project, China (#2020TG006),
Fujian Provincial Clinical Research Center for Cancer
Radiotherapy and Immunotherapy (#2020Y2012), and the
National Clinical Key Specialty Construction Program.
第一作者机构:[1]Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Lin Yu,Zheng Binglin,Chen Junqiang,et al.Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma[J].FRONTIERS IN ONCOLOGY.2023,13:doi:10.3389/fonc.2023.1059539.
APA:
Lin Yu,Zheng Binglin,Chen Junqiang,Huang Qiuyuan,Ye Yuling...&Xu Yuanji.(2023).Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma.FRONTIERS IN ONCOLOGY,13,
MLA:
Lin Yu,et al."Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma".FRONTIERS IN ONCOLOGY 13.(2023)